Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022

SELL
$4.02 - $16.84 $48,613 - $203,646
-12,093 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$9.26 - $31.31 $34,826 - $117,756
-3,761 Reduced 23.72%
12,093 $191,000
Q2 2021

Aug 12, 2021

BUY
$9.37 - $12.12 $30,518 - $39,474
3,257 Added 25.86%
15,854 $166,000
Q1 2021

May 03, 2021

BUY
$10.61 - $15.77 $133,654 - $198,654
12,597 New
12,597 $139,000

Others Institutions Holding BYSI

About BeyondSpring Inc.


  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $95.4M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.